October 11, 2019

June 22, 2019

13 European partners aim to accelerate patient access to innovative solutions

February 26, 2019

The principal Investigator Ruth M. Risueño will lead the development of a new class of drugs against Leukemia Stem Cells.

September 21, 2016

November 28, 2014

February 12, 2013

February 8, 2013

February 7, 2013

February 4, 2013

February 4, 2013

February 4, 2013

February 1, 2013

February 1, 2013

February 1, 2013

February 1, 2013

January 31, 2013

January 31, 2013

69 hospitals joined the plan, which ends in May

January 17, 2013

December 10, 2012

November 21, 2012

November 21, 2012

November 12, 2012

November 8, 2012

November 6, 2012

October 26, 2012

October 26, 2012

October 25, 2012

October 11, 2012

October 10, 2012

October 9, 2012

October 5, 2012

A study of Antares Consulting justify the measure, but not the time.

July 27, 2012

July 27, 2012

July 26, 2012

July 26, 2012

July 26, 2012

July 20, 2012

July 20, 2012

July 17, 2012

July 10, 2012

June 25, 2012

June 25, 2012

June 25, 2012

June 22, 2012

June 22, 2012

June 21, 2012

June 15, 2012

June 15, 2012

June 13, 2012

June 11, 2012

June 7, 2012

Elena de Mingo. Antares Consulting
Special International Lecture 2011 (Brazil)

June 1, 2012

Eduard Portella. President of Antares Consulting
Special International Lecture 2011

June 1, 2012

May 15, 2012

May 3, 2012

The report is produced with Antares Consulting

March 27, 2012

Copyright © 2019 Antares Consulting S.L. All rights reserved   |   Legal information and Privacy policy